IgA Nephropathy - 15 Studies Found
| RECRUITING |
: A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression : Primary IgA Nephropathy : 2024-11-21 : RO7434656 will be administered subcutaneously per schedule as specified. |
| RECRUITING |
: A Study of BION-1301 in Adults With IgA Nephropathy : IgA Nephropathy : 2024-11-21 : BION-1301 Pre-Filled Syringe (PFS) 600mg subcutaneous administration every 2 weeks for 104 weeks. |
| RECRUITING |
: Atacicept in Subjects With IgA Nephropathy : IgA Nephropathy : 2024-11-21 : Once weekly subcutaneous (SC) injections by prefilled syringe |
| RECRUITING |
: A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects : IgA Nephropathy : 2024-11-21 : Oral administration of specified dose of HS-10390 |
| COMPLETED |
: Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN : Primary IgA Nephropathy : 2024-11-21 : TARPEYO dispensing claim for any dose is exposure |